Key result
Orthostatic hypotension, affecting 10-30% of elderly individuals, requires a personalized, multidisciplinary management approach encompassing drug evaluation and non-pharmacological interventions.
Why the study?
Orthostatic hypotension affects 10-30% of elderly individuals and is linked to falls, cognitive deterioration, and cardiovascular issues, with aging, autonomic dysfunction, and medication use as primary factors.
Effective management of orthostatic hypotension in older adults requires a personalized, multidisciplinary approach including medication review and non-pharmacological interventions.
Answers are grounded in this paper and cite their sources.
Supports personalized orthostatic hypotension management in elderly patients; leaves open need for prospective trials to validate strategies.
INTRODUCTION: Orthostatic hypotension (OH) is a prevalent disorder among the elderly, characterized by a marked decrease in blood pressure upon standing. It impacts 10-30% of elderly individuals and is linked to falls, cognitive deterioration, and cardiovascular issues. The primary factors include aging, autonomic dysfunction, and pharmaceutical usage. METHODS: This narrative review consolidates and examines contemporary research regarding the etiology, pharmacological effects, diagnosis, and treatment of orthostatic hypotension in elderly adults. A systematic technique was not employed; rather, expert analysis of the existing literature was utilized to distill essential ideas. RESULTS: OH in the elderly is frequently complex. Frequently involved drugs encompass diuretics, β-blockers, calcium channel blockers, ACE inhibitors, antidepressants, and antiparkinsonian therapies. These medications, within the framework of age-associated physiological alterations, elevate the risk of orthostatic hypotension. The diagnosis relies on monitoring blood pressure during changes in posture. Non-pharmacological interventions, including water, sodium consumption, compression garments, and physical movements, constitute first-line therapies. In chronic instances, pharmacological treatments such as midodrine, droxidopa, and fludrocortisone may be employed, albeit with vigilant monitoring due to potential deleterious effects. DISCUSSION: OH significantly affects the autonomy and quality of life of elderly individuals. Medication- induced orthostatic hypotension is frequently disregarded, particularly in the context of polypharmacy. Customized management, encompassing drug evaluation and integrated therapy approaches, is crucial. Clinical monitoring and regular orthostatic evaluations are essential for prompt diagnosis and management. CONCLUSION: Effective OH management requires a personalized, multidisciplinary approach. Future research should focus on identifying reliable diagnostic biomarkers and developing individualized treatment algorithms to improve patient outcomes and support healthy aging.
No takes yet. Share an insight, caveat, or question.
Bhati et al. (2025) conducted a review in Orthostatic hypotension. Orthostatic hypotension, affecting 10-30% of elderly individuals, requires a personalized, multidisciplinary management approach encompassing drug evaluation and non-pharmacological interventions.
Synapse has enriched 10 related papers. Consider them for comparative context: